BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 29989571)

  • 1. [Oncolytic Paramyxoviruses: Mechanism of Action, Preclinical and Clinical Studies].
    Matveeva OV; Kochneva GV; Zainutdinov SS; Ilyinskaya GV; Chumakov PM
    Mol Biol (Mosk); 2018; 52(3):360-379. PubMed ID: 29989571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncolysis by paramyxoviruses: preclinical and clinical studies.
    Matveeva OV; Guo ZS; Senin VM; Senina AV; Shabalina SA; Chumakov PM
    Mol Ther Oncolytics; 2015; 2():15017-. PubMed ID: 26640815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of Oncolysis by Paramyxovirus Sendai.
    Matveeva OV; Kochneva GV; Netesov SV; Onikienko SB; Chumakov PM
    Acta Naturae; 2015; 7(2):6-16. PubMed ID: 26085940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncolysis by paramyxoviruses: multiple mechanisms contribute to therapeutic efficiency.
    Matveeva OV; Guo ZS; Shabalina SA; Chumakov PM
    Mol Ther Oncolytics; 2015; 2():15011-. PubMed ID: 26640816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage response to oncolytic paramyxoviruses potentiates virus-mediated tumor cell killing.
    Tan DQ; Zhang L; Ohba K; Ye M; Ichiyama K; Yamamoto N
    Eur J Immunol; 2016 Apr; 46(4):919-28. PubMed ID: 26763072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of attenuated paramyxoviruses for cancer therapy.
    Lech PJ; Russell SJ
    Expert Rev Vaccines; 2010 Nov; 9(11):1275-302. PubMed ID: 21087107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measles to the Rescue: A Review of Oncolytic Measles Virus.
    Aref S; Bailey K; Fielding A
    Viruses; 2016 Oct; 8(10):. PubMed ID: 27782084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced killing of therapy-induced senescent tumor cells by oncolytic measles vaccine viruses.
    Weiland T; Lampe J; Essmann F; Venturelli S; Berger A; Bossow S; Berchtold S; Schulze-Osthoff K; Lauer UM; Bitzer M
    Int J Cancer; 2014 Jan; 134(1):235-43. PubMed ID: 23797800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measles virus as an oncolytic vector platform.
    Blechacz B; Russell SJ
    Curr Gene Ther; 2008 Jun; 8(3):162-75. PubMed ID: 18537591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Modification of Oncolytic Newcastle Disease Virus for Cancer Therapy.
    Cheng X; Wang W; Xu Q; Harper J; Carroll D; Galinski MS; Suzich J; Jin H
    J Virol; 2016 Jun; 90(11):5343-5352. PubMed ID: 27009956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuated oncolytic measles virus strains as cancer therapeutics.
    Msaouel P; Iankov ID; Dispenzieri A; Galanis E
    Curr Pharm Biotechnol; 2012 Jul; 13(9):1732-41. PubMed ID: 21740361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel oncolytic viruses: riding high on the next wave?
    Stanford MM; Bell JC; Vähä-Koskela MJ
    Cytokine Growth Factor Rev; 2010; 21(2-3):177-83. PubMed ID: 20219409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncolytic viruses in cancer therapy.
    Vähä-Koskela MJ; Heikkilä JE; Hinkkanen AE
    Cancer Lett; 2007 Sep; 254(2):178-216. PubMed ID: 17383089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncolytic vaccinia virus: from bedside to benchtop and back.
    Thorne SH
    Curr Opin Mol Ther; 2008 Aug; 10(4):387-92. PubMed ID: 18683104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newcastle disease virus as an oncolytic agent.
    Ravindra PV; Tiwari AK; Sharma B; Chauhan RS
    Indian J Med Res; 2009 Nov; 130(5):507-13. PubMed ID: 20090097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viruses as nanomedicine for cancer.
    Badrinath N; Heo J; Yoo SY
    Int J Nanomedicine; 2016; 11():4835-4847. PubMed ID: 27703350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo.
    Heidbuechel JPW; Engeland CE
    J Vis Exp; 2019 Jan; (143):. PubMed ID: 30663684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virus combinations and chemotherapy for the treatment of human cancers.
    Kumar S; Gao L; Yeagy B; Reid T
    Curr Opin Mol Ther; 2008 Aug; 10(4):371-9. PubMed ID: 18683102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural and genetically engineered viral agents for oncolysis and gene therapy of human cancers.
    Sinkovics JG; Horvath JC
    Arch Immunol Ther Exp (Warsz); 2008 Dec; 56 Suppl 1():3s-59s. PubMed ID: 19104757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncolytic paramyxoviruses-induced autophagy; a prudent weapon for cancer therapy.
    Keshavarz M; Solaymani-Mohammadi F; Miri SM; Ghaemi A
    J Biomed Sci; 2019 Jun; 26(1):48. PubMed ID: 31217023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.